
Endocrinology/Hormones
Endocrinology/hormone inhibitors are compounds that block the action of hormones or interfere with hormone signaling pathways. These inhibitors are essential for studying the regulation of endocrine systems and for developing treatments for hormone-related diseases, such as diabetes, thyroid disorders, and hormone-dependent cancers. By modulating hormone activity, these inhibitors can help elucidate the complex interactions within the endocrine system. At CymitQuimica, we offer a wide range of high-quality endocrinology/hormone inhibitors to support your research in endocrinology, pharmacology, and medical sciences.
Subcategories of "Endocrinology/Hormones"
- Androgen Receptor(209 products)
- Annexin A(11 products)
- Aromatase(20 products)
- Estrogen/progestogen Receptor(49 products)
- GPR(1 products)
- Glucocorticoid Receptor(153 products)
- LHRH(1 products)
- Opioid Receptor(297 products)
- Prostaglandin Receptor(120 products)
- RAAS(87 products)
- Reductase(52 products)
- Somatostatin(49 products)
- Thyroid hormone receptor(THR)(26 products)
- Vasopressin Receptor(44 products)
Show 6 more subcategories
Found 3183 products of "Endocrinology/Hormones"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Inocoterone acetate
CAS:<p>Inocoterone acetate is a nonsteroidal antiandrogen that binds to the androgen receptor and possesses antiandrogenic activity in animal models.</p>Formula:C18H26O3Color and Shape:SolidMolecular weight:290.40TRIP13-IN-1
TRIP13-IN-1 (compound 20) is a potent ligand and inhibitor of TRIP13, demonstrating anticancer effects both in vivo and in vitro.Formula:C24H25NO9SColor and Shape:SolidMolecular weight:503.52Angiotensin II 5-valine
CAS:<p>ngiotensin II 5-valine is an angiotensin II analog which is an agonist at angiotensin receptors.</p>Formula:C49H69N13O12Purity:98%Color and Shape:SolidMolecular weight:N/AN-Desmethyl Loperamide
CAS:<p>N-Desmethyl Loperamide is the major metabolite of loperamide. It is also used as the precusor for radiolabelled loperamide.</p>Formula:C28H31ClN2O2Color and Shape:SolidMolecular weight:463.01BPR1M97
CAS:<p>BPR1M97 is a mu opioid receptor (MOP) and neuropeptide-orphin FQ (NOP) receptor agonist with blood-brain barrier permeability and potency, with Kis values of 1.</p>Formula:C18H18Cl2N2OPurity:98.78% - 99.95%Color and Shape:SolidMolecular weight:349.25PRO20
<p>PRO20 is a specific and competitive antagonist of the (pro)renin receptor (PRR). It inhibits the calcium influx induced by Proproin with an IC50 value of 81 nmol/L. By blocking the binding of Prorenin to PRR, PRO20 inhibits the activation of the renin-angiotensin system (RAS), reducing the production of angiotensin II (Ang II) and exerting antihypertensive effects. PRO20 holds promise for research in antihypertensive agents.</p>Color and Shape:Odour Solid[Arg14,Lys15]Nociceptin
CAS:<p>Potent NOP agonist (EC50 = 1 nM), >875x selective vs opioid receptors; outperforms nociceptin in vivo, increases pain perception, reduces movement.</p>Formula:C82H137N31O22Purity:98%Color and Shape:SolidMolecular weight:1909.18CP-472555
CAS:<p>CP-472555 is a selective nonsteroidal glucocorticoid receptor antagonist with anti-GR and anti-obesity activity in animal models.</p>Formula:C31H32N2O2Color and Shape:SolidMolecular weight:464.60Pro8-Oxytocin TFA
<p>Pro8-Oxytocin TFA, a modified oxytocin (OXT) ligand, exhibits greater potency and efficacy than the standard mammalian OXT ligand, Leu8-Oxytocin, at primate</p>Formula:C42H62N12O12S2·xC2HF3O2Purity:98%Color and Shape:SolidPRL 2915
CAS:<p>PRL 2915 is a potent antagonist of the human somatostatin subtype 2 receptor (hsst 2), exhibiting a binding affinity (K_i) of 12 nM [1].</p>Formula:C59H71ClN12O8S2Color and Shape:SolidMolecular weight:1175.85TF-505
CAS:<p>TF-505, a steroid 5α-reductase inhibitor, is used potentially for the treatment of benign prostatic hyperplasia.</p>Formula:C33H37NO4Purity:98%Color and Shape:SolidMolecular weight:511.65ERRγ agonist-2
CAS:<p>ERRγ agonist-2 is a potent and selective ERRγ inverse agonist with a K d value of 6.5 μM.</p>Formula:C27H21N5O2Color and Shape:SolidMolecular weight:447.49Neuropeptide AF (human) acetate
<p>Neuropeptide AF (human) acetate (Neuropeptide AF (human) acetate (192387-38-5 Free base)) is an anti-opioid neuropeptide, a Neuropeptide AF (human) derivative,</p>Purity:99.89%Color and Shape:SoildA 779
CAS:<p>A 779 is a potent antagonist of the G-protein-coupled receptor Mas, the Ang1-7 receptor, which is distinct from conventional AngII.</p>Formula:C39H60N12O11Purity:98%Color and Shape:SolidMolecular weight:872.97ARCC-4
CAS:<p>ARCC-4: A VHL-recruiting, low-nanomolar (DC50=5nM) AR degrader; outshines enzalutamide; degrades AR mutants resistant to therapy.</p>Formula:C53H56F3N7O7S2Purity:98%Color and Shape:SolidMolecular weight:1024.18Parathyroid hormone (1-34) (rat)
CAS:<p>Parathyroid hormone (PTH) receptor agonist. Increases serum PTH levels and bone mass in rats.</p>Formula:C180H291N55O48S2Purity:98%Color and Shape:SolidMolecular weight:4057.74THR-β agonist 6
CAS:<p>THR-β Agonist 6, a selective and orally active compound targeting the thyroid hormone receptor β (THR-β), demonstrates specificity with EC50 values of 0.03 μM</p>Formula:C20H14Cl2N6O3Color and Shape:SolidMolecular weight:457.27BWA-6047
<p>BWA-6047 is a dual AR/AR-V7 and GSPT1 PROTAC-type degrader (AR: DC50= 3.7 nM; AR-V7: DC50= 3.0 nM; GSPT1: DC50= 1.2 nM). It facilitates the ubiquitination and degradation of AR/AR-V7 and, through molecular glue properties, induces a PPI between GSPT1 and CRBN, leading to GSPT1 degradation. BWA-6047 is applicable in prostate cancer research.</p>Formula:C42H46ClN5O7Color and Shape:SolidMolecular weight:767.30858ARD-69
<p>ARD-69, a potent PROTAC, degrades AR in prostate cancer, with low DC50 values in AR+ cell lines, and suppresses AR gene expression.</p>Formula:C62H74ClFN8O7SColor and Shape:SolidMolecular weight:1129.83Lactandrate
CAS:<p>Lactandrate is a homo-aza-steroidal ester of p-bis(2-chloroethyl) amino phenyl acetic acid.</p>Formula:C31H44Cl2N2O3Color and Shape:SolidMolecular weight:563.6

